May 2, 2022 – Johnson & Johnson MedTech have announced that Biosense Webster, Inc., a worldwide leader in the science and technology of cardiac arrhythmia treatment, enrolled the first patients in its admIRE clinical study in the United States. admIRE is a prospective, multi-center, non-randomized study that will enroll more than 400 patients in the U.S.

May 2, 2022 – A method for delivering genetic material to the body is being tested as a way to repair damaged heart muscle after a heart attack.

May 2, 2022 – Inside embryonic cells, specific proteins control the rate at which genetic information is transcribed from DNA to messenger RNA – a crucial regulatory step before proteins are created. Then, organs develop and hopefully function properly. Those specific “regulatory” proteins are called transcription factors, and they do their thing by binding to specific DNA sequences at just the right time.

May 2, 2022 – High-risk patients who need defibrillators to prevent cardiac arrest can experience fewer complications with a type of device implanted under the skin, a Canadian study has found.

May 2, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), routine visual ordinal coronary artery calcium (CAC) assessment on all chest CT examinations could identify a large number of patients who might benefit from preventive therapies.

Image of late comedian Gilbert Gottfried from Wikipedia

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of April. This data was drawn from dicardiology.com’s 150,000 viewers over the course of the month.

1. Comedian Gilbert Gottfried Dies After Battle With Recurrent Ventricular Tachycardia

April 29, 2022 – Paragonix Technologies, Inc., a leading organ preservation provider, announces today groundbreaking research from a multi-center study on one-year transplant patient outcomes following heart transplant surgery.

April 29, 2022 – Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small vessel ischemic stroke patients who receive short-term or intermittent monitoring (i.e., Holter monitors and 30-day external monitors) may not be

April 29, 2022 – Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” evaluating the accuracy of cardiac mapping

April 29, 2022 – Aurora St. Luke’s Medical Center in Milwaukee is the first site in the country to join a clinical trial studying machine-learning software designed to help novice users perform an echocardiography exam.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now